Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Element Biosciences Stock

Q: How to sell Element Biosciences stock?

If you hold private company shares of Element Biosciences - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Element Biosciences stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

elementbiosciences.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $684.92MM

Element Biosciences is a company in the life sciences industry that focuses on genetic analysis methodology. Element Biosciences was founded in 2017 and is headquartered in San Diego, CA. The company provides access to advanced biological tools that strive to enable researchers to accelerate scientific discoveries. Specifically, Element Biosciences develops innovative DNA sequencing and multi-omics technology for biosciences research. The company's proprietary technology is called the AVITI system, and it offers high-quality sequencing intending to be at a lower cost than alternative methods.

Buy or sell Element Biosciences stockLearn more about Element Biosciences IPO

OverviewFinancingsValuation

Enterprise Value

Access Element Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Element Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Element Biosciences investors also invested in these private companies

Wellington Management

Wiz, Scale AI, Patreon, Element Biosciences, Greenlight, Omada Health, Away, Prove, Harry's, HeartFlow

Venrock

Element Biosciences, Dataminr, Rebellion Defense, Devoted Health, Aledade, Mashgin, Included Health, Cloudflare, ABL Space Systems, Astronomer

Meritech Capital Partners

Flock Safety, GoFundMe, Aviatrix, Element Biosciences, Wealthsimple, Verkada, DataStax, Webflow, Clickup, FloQast

Ra Capital Management

X-energy, Element Biosciences, Mindtickle, BioAge, Freenome, Capstan Therapeutics, Synthego, Sionna Therapeutics, FogPharma, Bicara Therapeutics

Fidelity Management & Research

Tenstorrent, Relativity Space, Epic Games, Nuro, Lightmatter, Element Biosciences, Astera Labs, Frore Systems, SiMa ai, Cleerly

T. Rowe Price

KoBold Metals, Databricks, Waymo, Redwood Materials, ADARx Pharmaceuticals, Sila Nanotechnologies, SandboxAQ, Tanium, Nuro, Stash

Morgan Stanley

AlphaSense, Securitize, Element Biosciences, Dataminr, Pipe, Lookout, Community, Rad Power Bikes, NYDIG, Foursquare

Foresite Capital

Altos Labs, Element Biosciences, Kriya Therapeutics, Mammoth Biosciences, Alumis, Delfi Diagnostics, Galileo Health, FogPharma, Inscripta, Crossover Health

Janus Henderson Investors

Element Biosciences, Freenome, Parse Biosciences, Scorpion Therapeutics, Carmot Therapeutics, Bicara Therapeutics, Obsidian Therapeutics, Bigfoot Biomedical, Asher Biotherapeutics, Lycia Therapeutics

Logos Capital

Element Biosciences, Attralus, Freenome, Synthego, Quanta Therapeutics, Parse Biosciences, Scorpion Therapeutics, Obsidian Therapeutics, Boundless Bio, Asher Biotherapeutics

Alexandria Venture Investments

Element Biosciences, Invaio, Tr1x, Ensoma, Tome Biosciences, Asher Biotherapeutics, Lycia Therapeutics, Odyssey Therapeutics

Samsung Electronics

Perplexity, Mistral AI, Element Biosciences, b.well Connected Health

Fusion Fund

Element Biosciences, Otter.ai, TVision

JS Capital Management

Element Biosciences

Team

Management Team

Molly He Ph.D

Co-Founder & Chief Executive Officer

Michael Previte Ph.D

Co-Founder, Senior Vice President of Research and Development & Chief Technology Officer

Matthew Kellinger Ph.D

Co-Founder & Vice President of Chemistry

Brian Stolz

Chief People Officer

Shawn Levy Ph.D

Chief Scientific Officer & Senior Vice President of Applications

David Melaugh

General Counsel

Francisco Garcia Ph.D

Senior Vice President of Informatics

Logan Zinser

Senior Vice President of Finance

Jeff Labbadia

Senior Vice President of Operations

Edwin Hauw

Senior Vice President of Marketing and Product Management

Yaron Hakak Ph.D

Senior Vice President of Corporate and Business Development

Danae Van Oene

Senior Vice President of Global Sales and Support

Board Members

James Tananbaum MD

Foresite Capital

Bryan Roberts Ph.D

Venrock

Element Biosciences stock FAQs

Can you buy Element Biosciences stock?

As Element Biosciences is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Element Biosciences, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Element Biosciences stock?

To invest in a private company like Element Biosciences through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Element Biosciences stock?

Yes, you may be able to sell your Element Biosciences stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Element Biosciences stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Element Biosciences stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Element Biosciences a public company?

No, Element Biosciences is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Element Biosciences’ stock price?

Element Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Element Biosciences’ private market stock price with Forge Data.

What is Element Biosciences’ stock ticker symbol?

Element Biosciences does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

PR Newswire 07/11/2024

Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth

In a series D funding round led by Wellington Management Element Biosciences raised $277 million.

Genomeweb 03/14/2022

Element Biosciences Unveils New DNA Sequencing Instrument, Chemistry

The San Diego-based startup plans to address the US research market with its Aviti short-read sequencing platform and Avidity sequencing chemistry.

Genomeweb 02/22/2022

Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products

The collaborations will make the Aviti platform compatible with NGS products from Roche, Agilent Technologies, New England Biolabs, Qiagen, and Watchmaker Genomics.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.